Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICXP007 plus standard of care in chronic neuropathic diabetic foot ulcers
2006-000692-15Phase 2Completed
- Sponsor
- Intercytex Group
- Start
- Apr 2006
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ICXP007 in diabetic foot ulcer (DFU), sponsored by Intercytex Group. Primary endpoint: Safety endpoints. Started Apr 2006; status: completed.
02
Drugs
ICXP007
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2006-000692-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000692-15.